A Multi‐Functional Cascade Nanoreactor for Remodeling Tumor Microenvironment to Realize Mitochondria Dysfunction via ROS/Zn<sup>2+</sup> Ions Overload
Combining chemo/photodynamic therapy (CDT/PDT) to generate highly harmful reactive oxygen species and cause mitochondria dysfunction is considered a potential strategy to improve the efficiency of anticancer treatment. However, within tumor, the relatively deficient concentration of H<sub>2</sub>O<sub>2</sub>, hypoxic microenvironment, and overexpressed reduced glutathione (GSH) seriously suppress the efficacy of dynamic therapy. Herein, a multi-functional cascade nanoreactor, bovine serum albumin modified ZnO<sub>2</sub>@CeO<sub>2</sub>-ICG, is reported for remodeling tumor microenvironment (TME) to boost dynamic therapy and realize mitochondria dysfunction via reactive oxygen species (ROS) storm/Zn<sup>2+</sup> ions overload. Within TME, ZnO<sub>2</sub> decomposed into exogenous H<sub>2</sub>O<sub>2</sub> and Zn<sup>2+</sup> ion. The dual enzyme-like CeO<sub>2</sub> catalyzes the increased H<sub>2</sub>O<sub>2</sub> into ·OH and oxygen molecules respectively, and then the oxygen molecules are translated into <sup>1</sup>O<sub>2</sub> by indocyanine green (ICG) under 808 nm light irradiation to boost PDT. The effective consumption of GSH through the reduction of Ce(IV) ions not only regenerates Ce(III) ions to enhance the efficiency of CDT but also efficaciously alleviates the elimination of ROS generated by dynamic therapy to further improve dynamic therapeutic efficiency. So the improved ROS level under remodeling TME and Zn<sup>2+</sup> ions acutely lead to mitochondria dysfunction to boost the efficiency of antitumor treatment. Thus, developing functional nanoreactors that enable remodeling TME provides a potential strategy to enhance the efficiency of dynamic therapy.
Authors
- Fengzhi Cui
- Shuyan Song (ORCID: https://orcid.org/0000-0002-7758-752X)
- Longhai Jin (ORCID: https://orcid.org/0000-0002-0248-5916)
- Songtao Zhang (ORCID: https://orcid.org/0000-0002-2463-4222)
- Meng Wu (ORCID: https://orcid.org/0000-0002-9277-1173)
- Jianhua Liu (ORCID: https://orcid.org/0000-0002-5856-8702)
- Tianqi Zhang (ORCID: https://orcid.org/0000-0002-3197-8947)
- Yinghui Wang (ORCID: https://orcid.org/0000-0001-7305-5852)
- Hongjie Zhang (ORCID: https://orcid.org/0000-0001-5433-8611)
- Shijie Zhou (ORCID: https://orcid.org/0000-0001-6411-7222)
- Haijia Yu
- Jianqiu Wang (ORCID: https://orcid.org/0000-0002-3150-1647)
Institutions
- University of Science and Technology of China (CN)
- Chinese Academy of Sciences (CN)
- Changchun Institute of Applied Chemistry (CN)
- Second Affiliated Hospital of Jilin University (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Small
- Published
- 2024-11-13
- DOI
- https://doi.org/10.1002/smll.202408639
- Citations
- 11
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 2.03
Funders
- Natural Science Foundation of Jilin Province
- Guangzhou Medical University
- National Natural Science Foundation of China
- Jilin University